CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE:EKG) today
announced expansion of the company's HeartCheck(TM) PEN 2012 Marketing and
Communications Campaign. In-print and on-line promotion will occur in
association with three major conferences: The Heart Rhythm Society Meeting
("HRS") in Boston specializing in the cardiac arrhythmia medical field, the
American Telemedicine Association Meeting ("ATA") in California which focuses on
global deployment of telemedicine technologies and the international World
Conference of Cardiology in Dubai (UAE). Further marketing and sales efforts
will continue via three in-print and on-line publication routes: the April
edition of HospiMedica International (English) and HospiMedica en Espanol
(Spanish); a 12 month listing as a featured company and a one year banner
campaign within the ATA on-line buyer's guide; and finally within the onsite
distribution of the CardioVascular Health publication at HRS, a publication
co-sponsored by CardioComm Solutions and initially distributed as an insert with
USA Today in February 2012.


"April and May will be busy months for CardioComm Solutions as we continue to
switch our marketing efforts into high gear. Our CEO has been organizing
pre-scheduled meetings at the events listed above, with device manufacturers
seeking integration options with FDA cleared and medically accredited software
back-end solutions. Other meetings with medical call center operators, large
distribution groups active in consumer as well as prescribed device sales and
strategic partners have also been scheduled," said Mr. Simi Grosman, member of
the Board of Directors for the Company.


The HospiMedic publication is in keeping with the Company's intent to support
the global entry of the HeartCheck(TM) PEN Handheld ECG device, GEMS(TM) Home
and the Smart Monitoring Solution into the consumer, over-the-counter and
prescribed health care markets. CardioComm Solutions' exposure through the April
issue will provide a targeted opportunity geared specifically to access medical
equipment purchasing and distribution networks. HospiMedica reaches 30,000 key
hospital decision makers and medical equipment dealers/distributors in Europe,
Latin America, the Middle East/Africa and Asia/Pacific. In addition the
HeartCheck(TM) PEN has been identified as a product of interest by the editors
of HospiMedica who have written a summary editorial piece entitled "Handheld ECG
Offers At-Home Cardiac Monitoring" to be published within the April issue.


"Timing is critical for developing market awareness of the HeartCheck(TM) brand
and CardioComm Solutions as a company. With the general public announcement made
in the USA Today CardioVascular Health insert in February, the redistribution of
that insert during HRS, the largest cardiac arrhythmia meeting in the USA,
advertising sponsorship within the web site for the flagship conference for
global access to telemedicine solutions and the release of the April edition of
HospiMedical, CardioComm Solutions will expand awareness of its products into
the international medical device markets. The publication will also be
circulated at this year's South-Asian Health Care Show, the World Cardiology
Congress, the 13th European Congress of Trauma and Emergency Surgery. Similar
efforts will be taken in advance of MEDICA 2013 (FRG) to increase awareness of
the HeartCheck(TM) PEN," says Etienne Grima, CEO of the Company. "Results of the
Heart and Stroke Foundation Atrial Fibrillaton ("AF") screening will also soon
be released demonstrating the appropriateness of the HeartCheck(TM) devices for
screening for AF in the asymptomatic population who are at heightened risk for
stroke," added Etienne.


About CardioComm Solutions

CardioComm Solution's patented and proprietary technology is used in products
for recording, viewing, analyzing and storing electrocardiograms (ECGs) for
diagnosis and management of cardiac patients. Products are sold worldwide
through a combination of an external distribution network and a North
American-based sales team. The company has earned the ISO 13485 certification,
is HPB approved, HIPAA compliant, and has received FDA market clearance for its
software devices. CardioComm Solutions, Inc. is headquartered in Toronto,
Canada, with offices in Victoria, B.C.


Forward-looking statements

This release may contain certain forward-looking statements with respect to the
financial condition, results of operations and business of CardioComm Solutions
and certain of the plans and objectives of CardioComm Solutions with respect to
these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will
occur in the future and there are many factors that could cause actual results
and developments to differ materially from those expressed or implied by these
forward-looking statements.
ATS Automation Tooling S... (TSX:ATA)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more ATS Automation Tooling S... Charts.
ATS Automation Tooling S... (TSX:ATA)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more ATS Automation Tooling S... Charts.